Market Overview:
The global chloroquine products market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of arthritis, malaria, COVID-19 and other diseases. Chloroquine is used as an anti-malarial drug and has been found to be effective in treating COVID-19. North America dominates the global chloroquine products market followed by Europe, Asia Pacific and Latin America.
Product Definition:
Chloroquine products are a group of medications that includes chloroquine and hydroxychloroquine. They are used to treat and prevent malaria, as well as other diseases caused by parasites.
250mg:
Chloroquine, also known as hydroxychloroquine sulfate or Quinoric acid, is an immunosuppressive drug with anti-viral properties. It's most commonly used to treat malaria and other diseases caused by P. falciparum and P. vivax species of the virus that causes Quincketia (enveloped viruses).
500mg:
500mg is a standard dose for chloroquine products. It can be used in the treatment of malaria, rheumatoid arthritis, and lupus. 500 mg tablet or capsule may also be used as an anti-inflammatory drug to reduce swelling & inflammation caused by osteoarthritis.
Chloroquine is widely prescribed for malaria due to its ability to kill the malarial parasites in the body without any side effects.
Application Insights:
The malaria segment dominated the global chloroquine products market in 2017, accounting for over 45% of the overall revenue. The product is used to treat and prevent malaria infection. It is one of the most effective antimalarial drugs available in the market and has been a major therapeutic tool for centuries, especially in Africa where malaria remains a major health problem due to its high prevalence rate.
Chloroquine is an essential drug that helps reduce symptoms including fever, headache, nausea and vomiting caused by malignant tertian (fever-freeze) or quartan (fluctuating fever) falciparum malaria infections as well as severe anemia caused due to parasitemia. These factors are anticipated to drive demand from various application segments during the forecast period.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. The region accounted for a share of more than 50% of global revenue in 2017 owing to high product consumption coupled with increasing production capacities. China, India, Thailand and Vietnam are some of the major producers/suppliers operating within Asia Pacific region.
The demand for chloroquine products is anticipated to be driven by rising COVID-19 positive cases across countries such as India, China, Australia and Japan among others which has led to an increase in demand from these sectors. In addition, growing malaria incidence across regions such as Africa is also anticipated drive regional market growth over the forecast period. For instance; according to WHO statistics; there were around 92 million new cases reported globally (all ages) in 2016 due to malaria parasite infection which resulted into deaths approximately 727 thousand (0.3%) people annually since 2012 i n Africa alone).
Growth Factors:
- Increasing prevalence of malaria and other parasitic infections: The increasing prevalence of malaria and other parasitic infections is a major growth driver for the chloroquine products market. Malaria is a life-threatening disease caused by parasites that are transmitted to humans through the bites of infected mosquitoes. According to the World Health Organization (WHO), there were an estimated 216 million cases of malaria worldwide in 2016, resulting in 438,000 deaths. The majority of these cases occurred in Africa. Chloroquine is one of the most effective drugs against malaria and is recommended by WHO as first-line treatment for uncomplicated Plasmodium falciparum malaria.
- Rising demand from emerging markets: The rising demand from emerging markets is another key growth driver for the chloroquine products market. Emerging markets such as India, China, and Brazil are experiencing high economic growth rates, which has led to an increase in disposable income levels among consumers. This has resulted in an increase in spending on healthcare products, including those used to treat parasitic infections such as malaria.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chloroquine Products Market Research Report
By Type
250mg, 500mg
By Application
Arthritis, Malaria, COVID-19, Others
By Companies
Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Chloroquine Products Market Report Segments:
The global Chloroquine Products market is segmented on the basis of:
Types
250mg, 500mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arthritis, Malaria, COVID-19, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Sichuan Sunny Hope
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- CSPC Group
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group
Highlights of The Chloroquine Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg
- 500mg
- By Application:
- Arthritis
- Malaria
- COVID-19
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chloroquine Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chloroquine products are a type of medication used to treat malaria. They work by stopping the spread of the malaria parasite in your body.
Some of the major players in the chloroquine products market are Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chloroquine Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chloroquine Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chloroquine Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chloroquine Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chloroquine Products Market Size & Forecast, 2018-2028
4.5.1 Chloroquine Products Market Size and Y-o-Y Growth
4.5.2 Chloroquine Products Market Absolute $ Opportunity
Chapter 5 Global Chloroquine Products Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chloroquine Products Market Size Forecast by Type
5.2.1 250mg
5.2.2 500mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chloroquine Products Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chloroquine Products Market Size Forecast by Applications
6.2.1 Arthritis
6.2.2 Malaria
6.2.3 COVID-19
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chloroquine Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chloroquine Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chloroquine Products Analysis and Forecast
9.1 Introduction
9.2 North America Chloroquine Products Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chloroquine Products Market Size Forecast by Type
9.6.1 250mg
9.6.2 500mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chloroquine Products Market Size Forecast by Applications
9.10.1 Arthritis
9.10.2 Malaria
9.10.3 COVID-19
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chloroquine Products Analysis and Forecast
10.1 Introduction
10.2 Europe Chloroquine Products Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chloroquine Products Market Size Forecast by Type
10.6.1 250mg
10.6.2 500mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chloroquine Products Market Size Forecast by Applications
10.10.1 Arthritis
10.10.2 Malaria
10.10.3 COVID-19
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chloroquine Products Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chloroquine Products Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chloroquine Products Market Size Forecast by Type
11.6.1 250mg
11.6.2 500mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chloroquine Products Market Size Forecast by Applications
11.10.1 Arthritis
11.10.2 Malaria
11.10.3 COVID-19
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chloroquine Products Analysis and Forecast
12.1 Introduction
12.2 Latin America Chloroquine Products Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chloroquine Products Market Size Forecast by Type
12.6.1 250mg
12.6.2 500mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chloroquine Products Market Size Forecast by Applications
12.10.1 Arthritis
12.10.2 Malaria
12.10.3 COVID-19
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chloroquine Products Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chloroquine Products Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chloroquine Products Market Size Forecast by Type
13.6.1 250mg
13.6.2 500mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chloroquine Products Market Size Forecast by Applications
13.10.1 Arthritis
13.10.2 Malaria
13.10.3 COVID-19
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chloroquine Products Market: Competitive Dashboard
14.2 Global Chloroquine Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Rising Pharmaceutical
14.3.3 Sun Pharma
14.3.4 Shanghai Pharma
14.3.5 Sichuan Sunny Hope
14.3.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
14.3.7 CSPC Group
14.3.8 KPC Group
14.3.9 Jinghua Pharmaceutical Group
14.3.10 Zhongsheng Pharma
14.3.11 North China Pharmaceutical Group
